APA
GILD icon

Astoria Portfolio Advisors’s Gilead Sciences GILD Stock Holding History

Astoria Portfolio Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$575K Buy
4,555
+785
+21% +$103K 0.1% 160
2026
Q1 		$482K Buy
3,770
+46
+1% +$6.44K 0.1% 151
2025
Q4 		$558K Sell
3,724
-196
-5% -$23.8K 0.13% 123
2025
Q3 		$464K Buy
+3,920
New +$446K 0.12% 150
2023
Q3 		– Sell
-3,091
Closed -$237K – 172
2023
Q2 		$237K Buy
3,091
+39
+1% +$3.11K 0.09% 168
2023
Q1 		$251K Sell
3,052
-847
-22% -$70.2K 0.11% 159
2022
Q4 		$324K Buy
+3,899
New +$309K 0.15% 135

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Astoria Portfolio Advisors's GILD Position: Q2 2026 in Review

Astoria Portfolio Advisors increased its Gilead Sciences (GILD) stake by 21% in Q2 2026, buying an estimated $103K and bringing the position to 4,555 shares worth $575K. The position accounts for 0.1% of the portfolio, ranked #160.

Astoria Portfolio Advisors first reported a position in GILD in Q4 2022 and has held it in 7 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Astoria Portfolio Advisors held 4,555 shares of Gilead Sciences worth $575K as of Q2 2026.
  • Astoria Portfolio Advisors bought 785 Gilead Sciences shares in Q2 2026, an estimated $103K.
  • Gilead Sciences made up 0.1% of Astoria Portfolio Advisors's portfolio in Q2 2026, its #160 holding.
  • Astoria Portfolio Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 7 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Astoria Portfolio Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.